David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
TechnipFMC
FTI
$30.4B
| $120M | 0.08% |
3,475,898
+1,354,104
| +64% | +$40.8M |
|
277
PUT
Salesforce
CRM
$171B
| $119M | 0.08% |
437,200
+427,200
| +4,272% | +$114M |
|
278
CarMax
KMX
$8.82B
| $119M | 0.08% |
1,771,800
+1,759,274
| +14,045% | +$118M |
|
279
PTC Therapeutics
PTCT
$5.83B
| $119M | 0.08% |
2,437,697
+992,418
| +69% | +$47.1M |
|
280
United Parcel Service
UPS
$86.8B
| $119M | 0.08% |
1,176,399
+337,021
| +40% | +$33.2M |
|
|
EXE
281
Expand Energy Corp
EXE
$22.2B
| $118M | 0.08% |
1,007,650
+871,449
| +640% | +$97.2M |
|
282
PUT
Royal Bank of Canada
RY
$285B
| $118M | 0.08% |
892,100
-43,000
| -5% | -$5.26M |
|
|
283
CALL
Salesforce
CRM
$171B
| $116M | 0.08% |
+424,500
| New | +$113M |
|
284
Capital One
COF
$134B
| $115M | 0.08% |
540,736
+200,327
| +59% | +$37.4M |
|
285
PUT
Pfizer
PFE
$160B
| $115M | 0.08% |
4,724,700
-3,220,200
| -41% | -$75.1M |
|
286
CALL
Oracle
ORCL
$422B
| $114M | 0.08% |
522,900
+421,800
| +417% | +$68.1M |
|
287
TSMC
TSM
$2.17T
| $114M | 0.08% |
501,760
-2,525,980
| -83% | -$468M |
|
|
NVO
288
PUT
Novo Nordisk
NVO
$207B
| $113M | 0.08% |
1,640,500
+564,800
| +53% | +$38.4M |
|
289
PUT
Target
TGT
$75.1B
| $113M | 0.08% |
1,144,000
+516,500
| +82% | +$49.6M |
|
290
CALL
Broadcom
AVGO
$1.75T
| $113M | 0.08% |
408,900
+73,700
| +22% | +$16M |
|
291
PUT
Texas Instruments
TXN
$241B
| $112M | 0.08% |
539,200
+198,200
| +58% | +$35.2M |
|
|
NEE.PRR
292
DELISTED
NextEra Energy, Inc. 6.926% Corporate Units
NEE.PRR
| $112M | 0.08% |
+2,802,775
| New | +$112M |
|
293
CALL
ExxonMobil
XOM
$679B
| $109M | 0.08% |
1,013,000
-25,800
| -2% | -$2.76M |
|
294
Yum! Brands
YUM
$41.8B
| $108M | 0.08% |
729,606
+382,327
| +110% | +$55.8M |
|
295
Medpace
MEDP
$17.3B
| $108M | 0.08% |
343,563
+129,385
| +60% | +$38.8M |
|
296
Philip Morris
PM
$293B
| $108M | 0.08% |
590,685
-748,002
| -56% | -$128M |
|
|
NBIS
297
Nebius Group N.V.
NBIS
$59.6B
| $108M | 0.08% |
+1,943,969
| New | +$66.9M |
|
|
298
CALL
Pfizer
PFE
$160B
| $107M | 0.08% |
4,429,800
+1,782,800
| +67% | +$41.6M |
|
299
PUT
Chevron
CVX
$403B
| $107M | 0.08% |
748,500
+156,100
| +26% | +$22M |
|
300
UiPath
PATH
$8.49B
| $107M | 0.08% |
8,358,206
+3,744,765
| +81% | +$44.9M |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.